Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetes

JK Gupta, R Ravindrarajah, G Tilston, W Ollier, DM Ashcroft, AH Heald
doi: https://doi.org/10.1101/2023.08.12.23294016

Data Availability

The datasets generated during and analysed during the current study are not publicly available as all data access is subject to review by Health Innovation Manchester.

Back to top
Posted August 19, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Association of polypharmacy and burden of comorbidities on COVID-19 adverse outcomes in people with type 1 or type 2 diabetes
JK Gupta, R Ravindrarajah, G Tilston, W Ollier, DM Ashcroft, AH Heald
medRxiv 2023.08.12.23294016; doi: https://doi.org/10.1101/2023.08.12.23294016
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area